| Norwest Minerals Limited (NWM) ORDINARY FULLY PAID |
Materials |
$12 |
Entitlement Offer Closing Date reminder
|
15 May 2025 8:25AM |
$0.012 |
$0.012 |
fallen by
0%
|
|
| Orica Limited (ORI) ORDINARY FULLY PAID |
Materials |
$12,112 |
Update - Notification of buy-back - ORI
|
15 May 2025 8:25AM |
$18.540 |
$25.950 |
risen by
39.97%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,646 |
Net Tangible Asset Backing
|
15 May 2025 8:25AM |
$2.780 |
$4.180 |
risen by
50.36%
|
|
| Jumbo Interactive Limited (JIN) ORDINARY FULLY PAID |
Consumer Discretionary |
$715 |
Update - Notification of buy-back - JIN
|
15 May 2025 8:25AM |
$10.010 |
$11.290 |
risen by
12.79%
|
|
| Structural Monitoring Systems Plc (SMN) CHESS DEPOSITARY INTERESTS 1:1 |
Information Technology |
$59 |
Change of Director's Interest Notice
|
15 May 2025 8:24AM |
$0.450 |
$0.380 |
fallen by
15.56%
|
|
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$2,751 |
ORA - Global Glass Leadership Announcement
|
15 May 2025 8:24AM |
$1.920 |
$2.230 |
risen by
16.15%
|
|
ORA - Price-sensitive ASX Announcement
Full Release
Key Points
- Orora Limited announced leadership changes in its Global Glass division.
- A new President, Global Glass, has been appointed.
- The appointment is aimed at supporting the company's growth strategy in glass operations.
- The new leader brings extensive industry experience.
- The leadership change aligns with Orora's commitment to operational excellence and market expansion.
- The company expects the new leadership to contribute positively to its global strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atturra Limited (ATA) ORDINARY FULLY PAID |
Information Technology |
$240 |
Update - Notification of buy-back - ATA
|
15 May 2025 8:24AM |
$0.880 |
$0.645 |
fallen by
26.70%
|
|
| Paradigm Biopharmaceuticals Limited (PAR) ORDINARY FULLY PAID |
Health Care |
$141 |
PAR Receives US Ethics Approval for Phase 3
|
15 May 2025 8:24AM |
$0.355 |
$0.330 |
fallen by
7.04%
|
|
PAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Paradigm Biopharmaceuticals Limited (PAR) received US Ethics Approval for Phase 3 PARA_OA_002 trial.
- The trial will study pentosan polysulfate sodium (PPS) for treating knee osteoarthritis pain.
- Approval comes from a central institutional review board, allowing patient recruitment in the US.
- Patient recruitment is expected to begin in June 2024.
- The trial is multicentre, randomized, double-blind, and placebo-controlled.
- Primary endpoint focuses on reduction in patient-reported knee pain.
- Target enrollment is approximately 1000 participants globally.
- The US will be a key site for patient recruitment.
- This milestone supports PPS advancement as a new potential treatment for osteoarthritis pain.
- Paradigm emphasizes its commitment to meeting the unmet needs in osteoarthritis pain management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VGI Partners Global Investments Limited (VG1) ORDINARY FULLY PAID |
Financials |
$480 |
Update - Notification of buy-back - VG1
|
15 May 2025 8:24AM |
$1.630 |
$1.950 |
risen by
19.63%
|
|
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
- |
Successful Completion of Share Purchase Plan
|
15 May 2025 8:24AM |
$0.095 |
$0.022 |
fallen by
76.84%
|
|
MDR - Price-sensitive ASX Announcement
Full Release
Key Points
- MedAdvisor Limited successfully completed its Share Purchase Plan (SPP), raising approximately $7.2 million.
- The SPP was announced on 24 May 2021 and closed on 21 June 2021.
- Eligible existing shareholders were given the opportunity to subscribe for new fully paid ordinary shares at an issue price of $0.45 per share.
- The SPP was strongly supported, resulting in applications exceeding the targeted amount.
- Due to the oversubscription, a scale-back of applications was applied in line with the terms of the SPP.
- The new shares issued under the SPP rank equally with existing MedAdvisor ordinary shares.
- The funds raised will be used to support the company's growth strategy, including investment in product development, international expansion, and working capital.
- MedAdvisor thanked shareholders for their strong support and reaffirmed its commitment to delivering shareholder value.
- The completion of the SPP follows the successful placement to institutional and sophisticated investors announced earlier.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RPMGlobal Holdings Limited (RUL) ORDINARY FULLY PAID |
Information Technology |
$1,101 |
Notification of cessation of securities - RUL
|
15 May 2025 8:24AM |
$2.860 |
$4.970 |
risen by
73.78%
|
|
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$2,751 |
ORA - Investor Update May 2025
|
15 May 2025 8:24AM |
$1.920 |
$2.230 |
risen by
16.15%
|
|
ORA - Price-sensitive ASX Announcement
Full Release
Key Points
- Orora Limited reports robust financial results with continued earnings growth.
- Focus on sustainable packaging solutions and innovation to meet changing customer demands.
- Strategic capital management includes share buy-backs and disciplined investment.
- Expansion efforts through targeted acquisitions, particularly in the North American market.
- Operational efficiency drives margin improvements across core businesses.
- Macroeconomic challenges addressed through cost management and supply chain resilience.
- Commitment to ESG principles with clearly outlined sustainability targets.
- Positive outlook for future growth underpinned by a diversified business model and strong balance sheet.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anagenics Limited (AN1) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Change of Director's Interest Notice
|
15 May 2025 8:24AM |
$0.006 |
$0.006 |
fallen by
0%
|
|
| Minbos Resources Limited (MNB) ORDINARY FULLY PAID |
Materials |
$30 |
Cabinda Phosphate Finance and Sales Update
|
15 May 2025 8:24AM |
$0.038 |
$0.027 |
fallen by
28.95%
|
|
MNB - Price-sensitive ASX Announcement
Full Release
Key Points
- Minbos Resources Limited provided an update on Cabinda Phosphate Project finance and sales activities.
- The company is progressing discussions with financiers for project funding.
- Offtake agreements and sales negotiations with potential buyers are actively underway.
- Engagement with international banks and export credit agencies is a key focus.
- Government support has been secured for the project development.
- The company is negotiating commercial terms for the sale of phosphate products.
- Milestones include finalizing credit approvals and offtake terms.
- Operational and regulatory requirements are being addressed for project advancement.
- Financial close is targeted to align with sales and offtake agreements.
- Timelines for funding and sales commencement are outlined based on ongoing negotiations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RPMGlobal Holdings Limited (RUL) ORDINARY FULLY PAID |
Information Technology |
$1,101 |
Update - Notification of buy-back - RUL
|
15 May 2025 8:23AM |
$2.860 |
$4.970 |
risen by
73.78%
|
|
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$77 |
Initial Director's Interest Notice
|
15 May 2025 8:23AM |
$0.080 |
$0.160 |
risen by
100%
|
|
| PVW Resources Limited (PVW) ORDINARY FULLY PAID |
Materials |
$8 |
Brazilian Rare Earths Portfolio Update
|
15 May 2025 8:23AM |
$0.012 |
$0.022 |
risen by
83.33%
|
|
PVW - Price-sensitive ASX Announcement
Full Release
Key Points
- PVW Resources Limited provided an update on its Brazilian Rare Earths Portfolio.
- The company has secured a significant landholding in Brazil, targeting ionic clay-hosted rare earth elements (REE) within the states of Minas Gerais and Bahia.
- PVW’s exploration approach is focused on identifying and developing high-grade rare earth mineralization in these ionic clays.
- Initial reconnaissance and sampling programs have confirmed the presence of rare earth elements, including high-value magnet rare earths such as neodymium and praseodymium.
- Several exploration licenses are in place and more are pending approval, covering more than 1,000 square kilometers.
- The company’s geological team is leveraging experience from established REE-producing regions, particularly in China and Brazil, to guide exploration activities.
- PVW is prioritizing areas with existing artisanal mining activity, favorable geology, and historical data indicating rare earth potential.
- The update highlights ongoing and planned activities, including drilling, systematic sampling, and metallurgical testing, to define resource potential and extraction viability.
- PVW is actively engaging with local communities and stakeholders to ensure responsible exploration practices.
- The company positions itself to benefit from increasing demand for rare earth elements driven by the global transition to renewable energy and electric vehicles.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Janus Henderson Sustainable Credit Active ETF (Managed Fund) (GOOD) |
Financials |
$3 |
Monthly Factsheet - April 2025
|
15 May 2025 8:23AM |
$50.830 |
$50.700 |
fallen by
0.26%
|
|
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$358 |
Update - Notification of buy-back - SVR
|
15 May 2025 8:23AM |
$1.715 |
$1.895 |
risen by
10.50%
|
|
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$513 |
Update - Notification of buy-back - ACL
|
15 May 2025 8:23AM |
$3.040 |
$2.670 |
fallen by
12.17%
|
|
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$6,125 |
Update - Notification of buy-back - DNL
|
15 May 2025 8:23AM |
$2.660 |
$3.430 |
risen by
28.95%
|
|
| Pepper Money Limited (PPM) ORDINARY FULLY PAID |
Financials |
$907 |
Update - Notification of buy-back - PPM
|
15 May 2025 8:23AM |
$1.705 |
$2.040 |
risen by
19.65%
|
|
| Vita Life Sciences Limited (VLS) ORDINARY FULLY PAID |
Health Care |
$154 |
Update - Notification of buy-back - VLS
|
15 May 2025 8:23AM |
$1.850 |
$2.820 |
risen by
52.43%
|
|
| Sims Limited (SGM) ORDINARY FULLY PAID |
Materials |
$3,811 |
Application for quotation of securities - SGM
|
15 May 2025 8:23AM |
$15.430 |
$19.720 |
risen by
27.80%
|
|
| WA1 Resources Ltd (WA1) ORDINARY FULLY PAID |
Materials |
$1,395 |
West Arunta Project - Luni Assay Results
|
15 May 2025 8:23AM |
$12.520 |
$18.780 |
risen by
50%
|
|
WA1 - Price-sensitive ASX Announcement
Full Release
Key Points
- WA1 Resources Ltd provides new assay results from Luni prospect, West Arunta Project.
- Significant high-grade niobium and rare earth element (REE) mineralisation confirmed.
- Drilling results show broad, continuous, and thick zones of mineralisation.
- Several drill holes returned standout intercepts, reinforcing the project's significance.
- Mineralised zones continue to expand with ongoing drilling and exploration work.
- The Luni prospect is highlighted as a major new discovery for niobium and REEs in Australia.
- WA1 Resources Ltd plans to continue drilling to further delineate mineralised zones.
- Project supports Australia's critical minerals strategy by focusing on niobium and REEs.
- The announcement underlines the company's leading position in critical mineral exploration.
- Assay results and geological work are ongoing and will be updated as further data is received.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.